BullFrog AI (BFRG) announced that its collaboration with Sygnature Discovery specializing in drug discovery, has entered the commercial phase. With the formal sales kickoff on September 12, BullFrog AI’s proprietary BullFrog Data Networks platform is now actively being introduced to Sygnature’s global client base, representing a revenue opportunity estimated at $15-$30 million through 2028.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 55% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on BFRG: